Nuzenio

Marketbeat Heron Therapeutics

Marketbeat Heron Therapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Mon, 10 Aug 2026 14:37:56 GMTHeron Therapeutics Q2 2026 Earnings Call Transcript - MarketBeat

Mon, 10 Aug 2026 14:15:00 GMTHeron Therapeutics Q2 Earnings Call Highlights - MarketBeat

Mon, 10 Aug 2026 12:41:50 GMTHeron Therapeutics (NASDAQ:HRTX) Issues Earnings Results - MarketBeat

Sat, 08 Aug 2026 06:32:28 GMTWall Street Zen Upgrades Heron Therapeutics (NASDAQ:HRTX) to Sell - MarketBeat

Thu, 06 Aug 2026 12:39:34 GMTHeron Therapeutics, Inc. (NASDAQ:HRTX) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Wed, 05 Aug 2026 11:38:27 GMTHeron Therapeutics (NASDAQ:HRTX) Upgraded to Hold at Zacks Research - MarketBeat

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Marketbeat Heron Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

1 distinct publisher/source names are currently connected to this entity page.